
Police reports detailing Seagen CEO’s arrest raise questions about biotech’s response
Seagen, the $22 billion company Siegall co-founded in 1997, said he had taken a leave of absence sixteen days after the incident.
Read The StoryInside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox. And subscribe to STAT+ to access daily, market-moving coverage of the biotech sector — from startup funding to clinical trial readouts
Seagen, the $22 billion company Siegall co-founded in 1997, said he had taken a leave of absence sixteen days after the incident.
Read The Story